Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

Cómo citar

Manuela Aguilar‐Guisado, & Ildefonso Espigado, & Almudena Martín‐Peña, & Carlota Gudiol, & Cristina Royo, & José Falantes, & Lourdes Vázquez-López, & M. Montero, & Clara Rosso-Fernández, & Maria De Martino, & Rocío Parody, & José González‐Campos, & Sebastián Garzón-López, & Cristina Calderón‐Cabrera, & Pere Barba, & Nancy R. Rodriguez, & Montserrat Rovira, & Enrique Montero-Mateos, & Jordi Carratalà, & Josè Antonio Pérez-Simón, & José Miguel Cisneros (2017). Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial. https://doi.org/10.1016/s2352-3026(17)30211-9